Calliditas Therapeutics' Strategic Response to Asahi Kasei's Move
Strategic Actions by Calliditas Therapeutics
Calliditas Therapeutics AB (Nasdaq: CALT), has recently initiated important corporate actions following Asahi Kasei Corporation's significant announcement regarding share control. Asahi Kasei disclosed that it holds over 90% of the outstanding shares of Calliditas, leading to the Company's upcoming decisions.
Delisting of Common Shares and ADS Program Termination
Responding to Asahi Kasei's developments, Calliditas has resolved to apply for the delisting of its common shares from Nasdaq Stockholm. This move includes the American Depositary Shares (ADSs) from the Nasdaq Global Select Market, which is a critical step in their corporate restructuring efforts.
Current Trading Status
The final trading day for Calliditas’ common shares on Nasdaq Stockholm will be confirmed soon, pending Nasdaq's confirmation. This delisting marks a significant transition in Calliditas’ operational landscape.
Regulatory Filings and Future Steps
The Company plans to submit a Form 25 to the U.S. Securities and Exchange Commission (SEC) around mid-September. The delisting of the ADSs is expected to become effective shortly after, and the Company also aims to terminate its ADS program while suspending reporting obligations under the Securities Exchange Act.
Upcoming Extraordinary General Meeting
Following the directives from Asahi Kasei, Calliditas has convened an Extraordinary General Meeting to elect a new Board of Directors. This meeting is a pivotal moment for the Company, aimed at laying down strategic directions aligned with the new shareholder's vision.
Meeting Details
The scheduled meeting will address various critical governance matters, including board structure and strategic oversight.
Contact Information
For any inquiries regarding these developments, please reach out to:
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Phone: +46 76 403 35 43, Email: [email protected]
About Calliditas Therapeutics
Calliditas Therapeutics, headquartered in Stockholm, Sweden, specializes in developing groundbreaking therapies for orphan conditions that lack effective treatment options. The Company aims to innovate within the biopharma sector, addressing unmet medical needs with its focus on specific therapeutic areas. Calliditas’ shares are actively traded on Nasdaq Stockholm under the ticker CALTX, and its ADSs are listed under CALT on the Nasdaq Global Select Market. For more information, please visit Calliditas.com.
Frequently Asked Questions
What recent actions has Calliditas Therapeutics taken?
Calliditas has announced plans to delist from Nasdaq Stockholm and terminate its ADS program after Asahi Kasei's acquisition move.
What does delisting mean for Calliditas shareholders?
Delisting indicates that Calliditas shares will no longer be traded on public exchanges, which may impact liquidity for shareholders.
When is the Extraordinary General Meeting scheduled?
The Executive Board has convened the meeting to elect a new Board of Directors as a crucial governance step, although an exact date was not specified.
Who should be contacted for further information about Calliditas?
Inquiries can be directed to Åsa Hillsten, the Head of Investor Relations & Sustainability at Calliditas.
What focus area does Calliditas Therapeutics specialize in?
Calliditas focuses on developing innovative treatments for orphan diseases with significant unmet medical needs, positioning itself as a leader in the biopharma industry.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Plastic Caps and Closures Market Set to Reach USD 96.28 Billion
- Procaps Group Outlines Strategic Vision for Future Success
- DemandScience Achieves a Historic 11th Inc. 5000 Honor
- Sustainable Apparel Market Projected to Hit USD 24.53 Billion
- Fleet Management Software Market Growth to USD 93.17 Billion
- Optical Modulators Market Growth Metrics and Key Drivers
- The Surging Mixed Reality Market: Predicted to Hit USD 76.91 Billion
- ChartPath and WoundZoom Partner to Revolutionize Wound Care
- Nutricosmetics Market Expected to Exceed $16.93 Billion Growth
- Ignitis Group Commits to 174 MW Tume Solar Project
- Caristo Diagnostics Recognized as a Quarterfinalist for Digital Health Award
- GeoVax Labs, Inc. Announces Upcoming Investor Events!
- John Ballantyne Joins Glucotrack Board to Advance Innovation
- Equip Exposition Appoints Chris Meecha as New Show Director
- Bango Partners with Disney+ to Expand Subscriber Offerings
- Semnur Pharmaceuticals and Denali Capital to Merge for Growth
- ThreatHunter.ai Launches Free Cybersecurity Tool for Businesses
- Treasure Global Inc Appoints New Directors to Enhance Growth
- Christian Lingua Earns Top Language Training Honor in Industry
- Roper Technologies to Showcase Innovations at GS Conference
- Celebree School Launches Campaign to Celebrate Literacy Month
- Kronos Bio to Showcase Research at Key Medical Conferences
- dxFeed Partners with PriceSquawk to Enhance Trading Experience
- RDE, Inc. Changes Ticker Symbol to GIFT for Growth
- Global Smart Airport Market Set to Reach 322 Billion USD by 2031
Recent Articles
- Understanding Nexans S.A. Share Capital and Voting Rights
- Steward Healthcare Faces Bankruptcy Challenges Next Week
- Monetary Metals Celebrates SOC 2 Certification Achievement
- Treasure Global Inc Appoints New Directors to Enhance Growth
- Mount Logan Capital Inc. Expands Workforce with New Hire
- Callinex Begins 2024 Exploration at Pine Bay Project Initiative
- Hearing Aids Market Projected to Reach $20.68 Billion by 2033
- Ceti AI: Transforming the Decentralized AI Landscape Today
- STRATA Skin Sciences CEO to Speak at H.C. Wainwright Event
- Nokia's Strategic Fibre Network Deal with AT&T
- Opthea's Upcoming Presentations at Investment Conferences
- Video Conferencing Solutions Market to Hit $49.7 Billion by 2032
- OTC Markets Integrates EDGAR Online Data into Nasdaq Platform
- Avoid Overpaying: Smart Tips for Holiday Car Hire Savings
- Battery Recycling Market Growth to Reach USD 37.49 Billion
- AT&T Webcast with John Stankey: Insights from Goldman Sachs
- Ensign Group Expands Reach with Seven New Facilities in Colorado
- Pakistan's PM Focuses on IMF Loan Program Completion Steps
- Gold Prices Drop as US Dollar Strengthens; Euro Surges
- Industrial 3D Printing Market Projected to Reach $88 Billion
- Esports World Cup Foundation Partners with Media Groups
- Agmatix Unveils RegenIQ: Revolutionizing Regenerative Agriculture
- TOPDON Unveils Innovative Automotive Diagnostics at Frankfurt
- RFID Market Forecast: Surging Towards USD 40 Billion by 2032
- Anticipation Rises as Jobs Report Approaches Market Challenges